San Antonio-Based Startup Perytor Therapeutics Developing Anti-Inflammatory Treatment

Updated: Apr 24, 2021

Local startup Perytor Therapeutics was named one of the most fundable startups in the U.S. by Pepperdine University Graziadio Business School’s 20 Most fundable Companies in 2020. Launched in 2020, they are commercializing its discovery of a substance that combats inflammation and has the regenerative properties stem cells possess.

Perytor founder and chief executive officer (CEO) Ramon Coronado said the active agent in stem cells provides the dual benefits of reducing inflammation and stimulating tissue regeneration. The Perytor treatment is a new category of therapeutic that helps patients with many conditions, such as degenerative joint disease and more severe conditions like inflammation of the lung from chronic obstructive pulmonary disease (COPD).

See the full story in Startup San Antonio.

Photo courtesy of Startup San Antonio.